183 related articles for article (PubMed ID: 23396489)
1. Imaging descriptors improve the predictive power of survival models for glioblastoma patients.
Mazurowski MA; Desjardins A; Malof JM
Neuro Oncol; 2013 Oct; 15(10):1389-94. PubMed ID: 23396489
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
3. Elderly patients with newly diagnosed glioblastoma: can preoperative imaging descriptors improve the predictive power of a survival model?
Park M; Lee SK; Chang JH; Kang SG; Kim EH; Kim SH; Song MK; Ma BG; Ahn SS
J Neurooncol; 2017 Sep; 134(2):423-431. PubMed ID: 28674975
[TBL] [Abstract][Full Text] [Related]
4. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.
Nicolasjilwan M; Hu Y; Yan C; Meerzaman D; Holder CA; Gutman D; Jain R; Colen R; Rubin DL; Zinn PO; Hwang SN; Raghavan P; Hammoud DA; Scarpace LM; Mikkelsen T; Chen J; Gevaert O; Buetow K; Freymann J; Kirby J; Flanders AE; Wintermark M;
J Neuroradiol; 2015 Jul; 42(4):212-21. PubMed ID: 24997477
[TBL] [Abstract][Full Text] [Related]
5. The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated
Choi YS; Ahn SS; Lee HJ; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
AJNR Am J Neuroradiol; 2017 Aug; 38(8):1528-1535. PubMed ID: 28642265
[TBL] [Abstract][Full Text] [Related]
6. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma.
Rao A; Rao G; Gutman DA; Flanders AE; Hwang SN; Rubin DL; Colen RR; Zinn PO; Jain R; Wintermark M; Kirby JS; Jaffe CC; Freymann J;
J Neurosurg; 2016 Apr; 124(4):1008-17. PubMed ID: 26473782
[TBL] [Abstract][Full Text] [Related]
7. Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients.
Peeken JC; Hesse J; Haller B; Kessel KA; Nüsslin F; Combs SE
Strahlenther Onkol; 2018 Jun; 194(6):580-590. PubMed ID: 29442128
[TBL] [Abstract][Full Text] [Related]
8. Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.
Lee J; Jain R; Khalil K; Griffith B; Bosca R; Rao G; Rao A
AJNR Am J Neuroradiol; 2016 Jan; 37(1):37-43. PubMed ID: 26471746
[TBL] [Abstract][Full Text] [Related]
9. An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning.
Senders JT; Staples P; Mehrtash A; Cote DJ; Taphoorn MJB; Reardon DA; Gormley WB; Smith TR; Broekman ML; Arnaout O
Neurosurgery; 2020 Feb; 86(2):E184-E192. PubMed ID: 31586211
[TBL] [Abstract][Full Text] [Related]
10. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
11. Computer-extracted MR imaging features are associated with survival in glioblastoma patients.
Mazurowski MA; Zhang J; Peters KB; Hobbs H
J Neurooncol; 2014 Dec; 120(3):483-8. PubMed ID: 25151504
[TBL] [Abstract][Full Text] [Related]
12. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
13. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.
Mangla R; Singh G; Ziegelitz D; Milano MT; Korones DN; Zhong J; Ekholm SE
Radiology; 2010 Aug; 256(2):575-84. PubMed ID: 20529987
[TBL] [Abstract][Full Text] [Related]
14. Radiomics in peritumoral non-enhancing regions: fractional anisotropy and cerebral blood volume improve prediction of local progression and overall survival in patients with glioblastoma.
Kim JY; Yoon MJ; Park JE; Choi EJ; Lee J; Kim HS
Neuroradiology; 2019 Nov; 61(11):1261-1272. PubMed ID: 31289886
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
[TBL] [Abstract][Full Text] [Related]
16. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
17. Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.
Yuan G; Niu L; Zhang Y; Wang X; Ma K; Yin H; Dai J; Zhou W; Pan Y
J Neurooncol; 2017 May; 133(1):193-201. PubMed ID: 28516344
[TBL] [Abstract][Full Text] [Related]
18. Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma.
Fathi Kazerooni A; Akbari H; Shukla G; Badve C; Rudie JD; Sako C; Rathore S; Bakas S; Pati S; Singh A; Bergman M; Ha SM; Kontos D; Nasrallah M; Bagley SJ; Lustig RA; O'Rourke DM; Sloan AE; Barnholtz-Sloan JS; Mohan S; Bilello M; Davatzikos C
JCO Clin Cancer Inform; 2020 Mar; 4():234-244. PubMed ID: 32191542
[TBL] [Abstract][Full Text] [Related]
19. Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Pérez-Beteta J; Molina-García D; Martínez-González A; Henares-Molina A; Amo-Salas M; Luque B; Arregui E; Calvo M; Borrás JM; Martino J; Velásquez C; Meléndez-Asensio B; de Lope ÁR; Moreno R; Barcia JA; Asenjo B; Benavides M; Herruzo I; Lara PC; Cabrera R; Albillo D; Navarro M; Pérez-Romasanta LA; Revert A; Arana E; Pérez-García VM
Eur Radiol; 2019 Apr; 29(4):1968-1977. PubMed ID: 30324390
[TBL] [Abstract][Full Text] [Related]
20. Conditional probability of survival in patients with newly diagnosed glioblastoma.
Polley MY; Lamborn KR; Chang SM; Butowski N; Clarke JL; Prados M
J Clin Oncol; 2011 Nov; 29(31):4175-80. PubMed ID: 21969507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]